F16.21 Hallucinogen dependence, in remission

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

Applicable To

Other hallucinogen use disorder, moderate, in early remission
Other hallucinogen use disorder, moderate, in sustained remission
Other hallucinogen use disorder, severe, in early remission
Other hallucinogen use disorder, severe, in sustained remission
Phencyclidine use disorder, moderate, in early remission
Phencyclidine use disorder, moderate, in sustained remission
Phencyclidine use disorder, severe, in early remission
Phencyclidine use disorder, severe, in sustained remission

GEM Conversion to ICD-9 CM


Back Reference of Diagnostic Codes

Dependence (on) (syndrome) F19.20
Disorder (of) See also Disease
hallucinogen use
in remission (early) (sustained) F16.21
phencyclidine use
in remission (early) (sustained) F16.21

Sibling Codes


Parent Sibling Codes


View in Tabular

Code Title
F01-F99 Mental, Behavioral and Neurodevelopmental disorders (F01-F99)
F10-F19 Mental and behavioral disorders due to psychoactive substance use (F10-F19)
F16 Hallucinogen related disorders
F16.2 Hallucinogen dependence
F16.21 Hallucinogen dependence, in remission
Applicable to
Other hallucinogen use disorder, moderate, in early remission
Other hallucinogen use disorder, moderate, in sustained remission
Other hallucinogen use disorder, severe, in early remission
Other hallucinogen use disorder, severe, in sustained remission
Phencyclidine use disorder, moderate, in early remission
Phencyclidine use disorder, moderate, in sustained remission
Phencyclidine use disorder, severe, in early remission
Phencyclidine use disorder, severe, in sustained remission